首页> 外文OA文献 >Synthesis, Spectral Characterization, and Biochemical Evaluation of Antidiabetic Properties of a New Zinc-Diosmin Complex Studied in High Fat Diet Fed-Low Dose Streptozotocin Induced Experimental Type 2 Diabetes in Rats
【2h】

Synthesis, Spectral Characterization, and Biochemical Evaluation of Antidiabetic Properties of a New Zinc-Diosmin Complex Studied in High Fat Diet Fed-Low Dose Streptozotocin Induced Experimental Type 2 Diabetes in Rats

机译:在高脂饮食中研究的新锌 - 二孢素复合物的抗糖尿病性能和生化评价在大鼠高脂饮食中研究的新锌 - 二孢子复合物的生化评价及大鼠实验2型糖尿病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In view of the established antidiabetic properties of zinc, the present study was aimed at evaluating the hypoglycemic properties of a new zinc-diosmin complex in high fat diet fed-low dose streptozotocin induced experimental type 2 diabetes in rats. Zinc-diosmin complex was synthesized and characterized by various spectral studies. The complexation between zinc ions and diosmin was further evidenced by pH-potentiometric titrations and Job’s plot. Diabetic rats were orally treated with zinc-diosmin complex at a concentration of 20 mg/kg b.w./rat/day for 30 days. At the end of the experimental period, the rats were subjected to oral glucose tolerance test. In addition, HOMA-IR and various biochemical parameters related to glucose homeostasis were analyzed. Treatment with zinc-diosmin complex significantly improved the glucose homeostasis in diabetic rats. Treatment with zinc-diosmin complex significantly improved insulin sensitivity, at least in part, through enhancing protein metabolism and alteration in the levels of muscle and liver glycogen. The assay of clinical marker enzymes revealed the nontoxic nature of the complex. Determination of renal tissue markers such as blood urea and serum creatinine indicates the renoprotective nature of the complex. These findings suggest that zinc-diosmin complex is nontoxic and has complimentary potential to develop as an antihyperglycemic agent for the treatment of diabetes mellitus.
机译:鉴于锌的已建立的抗糖尿病性能,本研究旨在评估高脂饮食中新型锌 - 二孢素复合物的低血糖特性,大鼠大鼠高脂肪饮食中的高脂肪饮食中的糖尿病诱导的实验型2糖尿病。通过各种光谱研究合成锌 - 二孢子络合物,其特征在于各种光谱研究。通过pH-电位滴定和作业的情节进一步证明了锌离子和二孢菌素之间的络合。用锌 - 二孢子复合物口服糖尿病大鼠以20mg / kg B.w./rat/day浓度为30天。在实验期结束时,对大鼠进行口服葡萄糖耐量试验。此外,分析了与葡萄糖稳态有关的HOA-IR和各种生化参数。用锌 - 二孢子复合物治疗显着改善了糖尿病大鼠的葡萄糖稳态。用锌 - 二孢子复合物处理显着提高了胰岛素敏感性,至少部分地通过增强蛋白质代谢和肌肉和肝糖原水平的改变。临床标志物酶的测定揭示了复合物的无毒性质。血液尿素和血清肌酐等肾组织标志物的测定表明了复合物的肾上腺素性质。这些研究结果表明,锌 - 二孢菌素复合物是无毒的,具有互补的潜力,可作为治疗糖尿病治疗糖尿病的抗血糖药物。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号